Escherichia coli and Proteus mirabilis inhibit the perinuclear but not the circulating antineutrophil cytoplasmic antibody reaction

Scandinavian Journal of Gastroenterology
P YangG Järnerot

Abstract

Perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) are found in 48%-83% of serum samples from patients with ulcerative colitis (UC). Their pathogenic role and initiating stimuli are unknown. In contrast to patients with vasculitides and ANCA reactivities, the antibodies in UC patients do not react with myeloperoxidase (MPO) or proteinase 3 (PR3). The aim of the present study was to investigate whether bacterial species of the intestinal tract and other sources could interfere with P-ANCA in sera from patients with UC. Seventeen P-ANCA-positive and anti-MPO-negative serum samples from patients with UC were tested with Escherichia coli 014 and Staphylococcus aureus Wood 46. Six of these serum samples with different P-ANCA titres were selected to test further the influence of 15 different gram-negative or gram-positive bacterial strains. Six anti-MPO positive P-ANCA, 5 anti-PR3 positive C-ANCA, and 10 antinuclear antibody (ANA)-positive serum samples were used as controls. The antineutrophil cytoplasmic antibodies (ANCAs) were analysed by an indirect immunofluorescence method (IIF) on ethanol-fixed neutrophils, and the ANAs were tested by IIF on HEp-2 cells or rat liver tissues. The bacteria used in the experiments were ei...Continue Reading

References

Apr 1, 1990·Alimentary Pharmacology & Therapeutics·D A BurkeR W Lacey
Oct 1, 1995·European Journal of Gastroenterology & Hepatology·A LindgrenH Abrahamsson
Jul 1, 1967·Proceedings of the Society for Experimental Biology and Medicine·P PerlmannD Campbell

❮ Previous
Next ❯

Citations

May 26, 1999·Clinical and Experimental Immunology·C Roozendaal, C G Kallenberg

❮ Previous
Next ❯

Related Concepts